B2Venture

Calvin Risk specializes in assessing and managing risks associated with commercial AI algorithms. Based in Zurich, Switzerland, the company offers a comprehensive risk assessment framework and management platform, promoting reliable and responsible AI use across industries such as insurance, banking, retail, and telecommunications.

Calvin Risk specializes in assessing and managing risks associated with commercial AI algorithms. Based in Zurich, Switzerland, the company offers a comprehensive risk assessment framework and management platform, promoting reliable and responsible AI use across industries such as insurance, banking, retail, and telecommunications.

Calvin Risk specializes in assessing and managing risks associated with commercial AI algorithms. Based in Zurich, Switzerland, the company offers a comprehensive risk assessment framework and management platform, promoting reliable and responsible AI use across industries such as insurance, banking, retail, and telecommunications.

Araris Biotech AG is a biotechnology start-up based in Zurich, Switzerland, founded in 2019. The company specializes in developing antibody-drug conjugate (ADC) linker technology aimed at enhancing chemotherapy by delivering chemotherapeutic agents directly to targeted antibodies. This innovative platform allows for the rapid production of high-quality ADCs without the need for extensive engineering of antibodies or cell lines, enabling the use of readily available antibodies. The site-specific conjugation process facilitates swift manufacturing and reliable quality control, supporting the creation of safe and potent drugs for various diseases. Araris Biotech's technology is protected by two patents, underscoring its commitment to advancing cancer treatment through improved safety and tolerability for patients.

Skribble offers an electronic signature platform that ensures legally binding digital contracts, compliant with Swiss and EU laws. Founded in 2018, it enables users to sign documents electronically with just a few clicks.

Araris Biotech AG is a biotechnology start-up based in Zurich, Switzerland, founded in 2019. The company specializes in developing antibody-drug conjugate (ADC) linker technology aimed at enhancing chemotherapy by delivering chemotherapeutic agents directly to targeted antibodies. This innovative platform allows for the rapid production of high-quality ADCs without the need for extensive engineering of antibodies or cell lines, enabling the use of readily available antibodies. The site-specific conjugation process facilitates swift manufacturing and reliable quality control, supporting the creation of safe and potent drugs for various diseases. Araris Biotech's technology is protected by two patents, underscoring its commitment to advancing cancer treatment through improved safety and tolerability for patients.

Skribble offers an electronic signature platform that ensures legally binding digital contracts, compliant with Swiss and EU laws. Founded in 2018, it enables users to sign documents electronically with just a few clicks.

Arktis Radiation Detectors Ltd, founded in 2007 and based in Zurich, Switzerland, specializes in designing and manufacturing integrated detection systems for radiological and nuclear materials. The company employs a unique platform technology that utilizes compressed noble gas to achieve high levels of accuracy in detecting ionizing radiation, including fast neutrons and gamma radiation. Arktis offers a range of products, including radiation detection systems such as portal monitors, mobile monitoring systems, and networked detection solutions. Its technologies serve various applications, including border security, nuclear power, and health physics, addressing critical needs in threat mitigation and radiation safety. Additionally, the company provides consulting services in areas such as radiation shielding and health physics for both businesses and government entities.

DeepCode is a software company that develops artificial intelligence based semantic code analysis for software programming. Founded in 2016 and based in Zurich, it offers a system that analyzes source code to determine its intent, identify critical bugs and vulnerabilities, and improve software quality without requiring annotations or specifications. The technology merges program analysis with machine learning to help developers understand code and surface issues early in the development process.

Skribble offers an electronic signature platform that ensures legally binding digital contracts, compliant with Swiss and EU laws. Founded in 2018, it enables users to sign documents electronically with just a few clicks.

DeepCode is a software company that develops artificial intelligence based semantic code analysis for software programming. Founded in 2016 and based in Zurich, it offers a system that analyzes source code to determine its intent, identify critical bugs and vulnerabilities, and improve software quality without requiring annotations or specifications. The technology merges program analysis with machine learning to help developers understand code and surface issues early in the development process.

Advanon AG is a financial services platform based in Zurich, Switzerland, that specializes in invoice financing for small and medium-sized enterprises (SMEs). Founded in 2015 by Phil Lojacono, Philip Kornmann, and Stijn Pieper, Advanon connects businesses seeking liquidity with a network of financial investors willing to pre-finance their outstanding invoices. This service allows SMEs to access funds more rapidly, avoiding the lengthy wait times of 30 to 120 days typically associated with customer payments. As an authorized financial intermediary, Advanon is regulated under Swiss law, ensuring compliance with the Anti Money Laundering Act. The platform aims to provide flexible financing solutions with transparent pricing, enabling businesses to enhance their cash flow and support growth without incurring additional obligations.

Arktis Radiation Detectors Ltd, founded in 2007 and based in Zurich, Switzerland, specializes in designing and manufacturing integrated detection systems for radiological and nuclear materials. The company employs a unique platform technology that utilizes compressed noble gas to achieve high levels of accuracy in detecting ionizing radiation, including fast neutrons and gamma radiation. Arktis offers a range of products, including radiation detection systems such as portal monitors, mobile monitoring systems, and networked detection solutions. Its technologies serve various applications, including border security, nuclear power, and health physics, addressing critical needs in threat mitigation and radiation safety. Additionally, the company provides consulting services in areas such as radiation shielding and health physics for both businesses and government entities.

Arktis Radiation Detectors Ltd, founded in 2007 and based in Zurich, Switzerland, specializes in designing and manufacturing integrated detection systems for radiological and nuclear materials. The company employs a unique platform technology that utilizes compressed noble gas to achieve high levels of accuracy in detecting ionizing radiation, including fast neutrons and gamma radiation. Arktis offers a range of products, including radiation detection systems such as portal monitors, mobile monitoring systems, and networked detection solutions. Its technologies serve various applications, including border security, nuclear power, and health physics, addressing critical needs in threat mitigation and radiation safety. Additionally, the company provides consulting services in areas such as radiation shielding and health physics for both businesses and government entities.